In vitro efficacy of antimalarial drugs against circulating strains of the SARS-CoV-2 virus that causes COVID-19 in Panama.

  • Funded by Secretaría Nacional de Ciencia, Tecnología e Innovación (SENACYT)
  • Total publications:0 publications

Grant number: COVID19-041

Grant search

Key facts

  • Disease

    COVID-19
  • Known Financial Commitments (USD)

    $200,000
  • Funder

    Secretaría Nacional de Ciencia, Tecnología e Innovación (SENACYT)
  • Principal Investigator

    Dr. Nicanor Tercero Obaldía Rodríguez
  • Research Location

    Panama
  • Lead Research Institution

    Instituto Conmemorativo Gorgas de Estudios de la Salud (ICGES)
  • Research Priority Alignment

    N/A
  • Research Category

    Therapeutics research, development and implementation

  • Research Subcategory

    Prophylactic use of treatments

  • Special Interest Tags

    N/A

  • Study Type

    Unspecified

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Not Applicable

  • Vulnerable Population

    Not applicable

  • Occupations of Interest

    Not applicable

Abstract